Early gut colonization by Bifidobacterium breve and B. catenulatum differentially modulates eczema risk in children at high risk of developing allergic disease

Pediatric Allergy and Immunology

Volumn 27, Issue 8, 2016, Pages 838-846

  Ismail, Intan H ^a,b,c   Boyle, Robert J ^a,b,d   Licciardi, Paul V ^a,b   Oppedisano, Frances ^a   Lahtinen, Sampo ^a   Robins Browne, Roy M ^a,b,e   Tang, Mimi L K ^a,b,e  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

atopic sensitization; Bifidobacterium breve; Bifidobacterium catenulatum; eczema; gut microbiota; terminal restriction fragment length polymorphism

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; BACTERIAL DNA; DNA 16S; IMMUNOGLOBULIN E; MALTODEXTRIN; PROBIOTIC AGENT; RESTRICTION ENDONUCLEASE; YOGHURT;

ALLERGIC DISEASE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL MILK; ATOPY; BACTERIAL COLONIZATION; BACTERIAL COUNT; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANGULATUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM INFANTIS; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CONTROLLED STUDY; DAY CARE; ECZEMA; ENZYME DEGRADATION; FECES ANALYSIS; FEMALE; GEL ELECTROPHORESIS; HIGH RISK INFANT; HOUSEHOLD; HUMAN; INFANT; INFANT FEEDING; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PET ANIMAL; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SIBLING; BACTERIAL INFECTION; FECES; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; MICROBIOLOGY; RISK; SKIN TEST;

BACTERIAL INFECTIONS; BIFIDOBACTERIUM BREVE; DNA, BACTERIAL; ECZEMA; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; MALE; PROBIOTICS; RISK; SKIN TESTS;

EID: 84995952461     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12646     Document Type: Article

References (36)

1. Wopereis H, Oozeer R, Knipping K, Belzer C, Knol J. The first thousand days – intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol 2014: 25: 428–38.
2. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001: 108: 516–20.
3. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001: 107: 129–34.
4. Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009: 39: 518–26.
5. Penders J, Stobberingh EE, Thijs C, et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006: 36: 1602–8.
6. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997: 159: 1739–45.
7. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008: 121: 129–34.
8. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol 2011: 128: 646–52. e1-5.
9. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012: 129: e2.
10. Ismail IH, Oppedisano F, Joseph SJ, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 2012: 23: 674–81.
11. Gore C, Munro K, Lay C, et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008: 121: 135–40.
12. Suzuki S, Shimojo N, Tajiri Y, Kumemura M, Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007: 37: 506–11.
13. Noval Rivas M, Burton OT, Wise P, et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J Allergy Clin Immunol 2013: 131: 201–12.
14. Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011: 66: 509–16.
15. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994: 131: 406–16.
16. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999: 65: 4506–12.
17. Gueimonde M, Tolkko S, Korpimaki T, Salminen S. New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Appl Environ Microbiol 2004: 70: 4165–9.
18. Lahtinen SJ, Boyle RJ, Kivivuori S, et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol 2009: 123: 499–501.
19. Adlerberth I, Strachan DP, Matricardi PM, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007: 120: 343–50.
20. Ouwehand AC, Isolauri E, He F, Hashimoto H, Benno Y, Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001: 108: 144–5.
21. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007: 51: 260–9.
22. de Roock S, van Elk M, van Dijk ME, et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010: 40: 103–10.
23. López P, Gueimonde M, Margolles A, Suárez A. Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 2010: 138: 157–65.
24. Inoue Y, Iwabuchi N, Xiao JZ, Yaeshima T, Iwatsuki K. Suppressive effects of bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. Biol Pharm Bull 2009: 32: 760–3.
25. Van De Pol MA, Lutter R, Smids BS, Weersink EJM, Van Der Zee JS. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy 2011: 66: 39–47.
26. Matsuki T, Watanabe K, Tanaka R. Genus- and species-specific PCR primers for the detection and identification of bifidobacteria. Curr Issues Intest Microbiol 2003: 4: 61–9.
27. He F, Morita H, Hashimoto H, et al. Intestinal Bifidobacterium species induce varying cytokine production. J Allergy Clin Immunol 2002: 109: 1035–6.
28. Pozo-Rubio T, Mujico JR, Marcos A, et al. Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system. Br J Nutr 2011: 106: 1216–23.
29. Duranti S, Milani C, Lugli GA, et al. Evaluation of genetic diversity among strains of the human gut commensal Bifidobacterium adolescentis. Sci Rep 2016: 6: 23971.
30. Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006: 118: 511–21.
31. Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol 2012: 2: 94.
32. Gueimonde M, Sakata S, Kalliomaki M, Isolauri E, Benno Y, Salminen S. Effect of Maternal Consumption of Lactobacillus GG on Transfer and Establishment of Fecal Bifidobacterial Microbiota in Neonates. J Pediatr Gastroenterol Nutr 2006: 42: 166–70.
33. Schultz M, Gottl C, Young RJ, Iwen P, Vanderhoof JA. Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization. J Pediatr Gastroenterol Nutr 2004: 38: 293–7.
34. Buddington RK, Williams CH, Kostek BM, Buddington KK, Kullen MJ. Maternal-to-infant transmission of probiotics: concept validation in mice, rats, and pigs. Neonatology 2010: 97: 250–6.
35. Makino H, Kushiro A, Ishikawa E, et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One 2013: 8: e78331.
36. Mikami K, Takahashi H, Kimura M, et al. Influence of maternal bifidobacteria on the establishment of bifidobacteria colonizing the gut in infants. Pediatr Res 2009: 65: 669–74.